CIRM Alpha Stem Cell Clinics: Collaboratively Addressing Regenerative Medicine Challenges

Catriona H.M. Jamieson, Maria T. Millan, Abla A. Creasey, Geoff Lomax, Mary E. Donohoe, Mark C. Walters, Mehrdad Abedi, Daniela A. Bota, John A. Zaia, John S. Adams

Research output: Contribution to journalComment/debate

3 Scopus citations

Abstract

The California Institute for Regenerative Medicine (CIRM) Alpha Stem Cell Clinic (ASCC) Network was launched in 2015 to address a compelling unmet medical need for rigorous, FDA-regulated, stem cell-related clinical trials for patients with challenging, incurable diseases. Here, we describe our multi-center experiences addressing current and future challenges. The California Institute for Regenerative Medicine (CIRM) Alpha Stem Cell Clinic (ASCC) Network was launched in 2015 to address a compelling unmet medical need for rigorous, FDA-regulated, stem cell-related clinical trials for patients with challenging, incurable diseases. Here, we describe our multi-center experiences addressing current and future challenges.

Original languageEnglish (US)
Pages (from-to)801-805
Number of pages5
JournalCell Stem Cell
Volume22
Issue number6
DOIs
StatePublished - Jun 1 2018

ASJC Scopus subject areas

  • Molecular Medicine
  • Genetics
  • Cell Biology

Fingerprint Dive into the research topics of 'CIRM Alpha Stem Cell Clinics: Collaboratively Addressing Regenerative Medicine Challenges'. Together they form a unique fingerprint.

  • Cite this

    Jamieson, C. H. M., Millan, M. T., Creasey, A. A., Lomax, G., Donohoe, M. E., Walters, M. C., Abedi, M., Bota, D. A., Zaia, J. A., & Adams, J. S. (2018). CIRM Alpha Stem Cell Clinics: Collaboratively Addressing Regenerative Medicine Challenges. Cell Stem Cell, 22(6), 801-805. https://doi.org/10.1016/j.stem.2018.05.007